Atrial Fibrillation

You have accessRestricted access
Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation
Emily C. O'Brien, DaJuanicia N. Holmes, Laine E. Thomas, Gregg C. Fonarow, Larry A. Allen, Bernard J. Gersh, Peter R. Kowey, Daniel E. Singer, Michael D. Ezekowitz, Gerald V. Naccarelli, Jack E. Ansell, Paul S. Chan, Kenneth W. Mahaffey, Alan S. Go, James V. Freeman, James A. Reiffel, Eric D. Peterson, Jonathan P. Piccini and Elaine M. Hylek

Circulation. 2018;CIRCULATIONAHA.117.031354, originally published April 20, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031354

Download PDF
You have accessRestricted access
Mobile Phone Detection of Atrial Fibrillation With MechanocardiographyThe MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation)
Jussi Jaakkola, Samuli Jaakkola, Olli Lahdenoja, Tero Hurnanen, Tero Koivisto, Mikko Pänkäälä, Timo Knuutila, Tuomas O. Kiviniemi, Tuija Vasankari and K.E. Juhani Airaksinen

Circulation. 2018;137:1524-1527, originally published March 11, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032804

Download PDF
You have accessRestricted access
Response by García-Granja et al to Letter Regarding Article, “Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?”
Pablo Elpidio García-Granja, María Sandín-Fuentes, Emilio García-Morán, Teresa Sevilla and Jerónimo Rubio

Circulation. 2018;137:1541-1542, originally published April 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032057

Download PDF
You have accessRestricted access
Letter by Spartalis et al Regarding Article, “Modifiable Risk Factors and Atrial Fibrillation”
Michael Spartalis, Eleni Tzatzaki and Eleftherios Spartalis

Circulation. 2018;137:1528-1529, originally published April 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031481

Download PDF
You have accessRestricted access
Letter by Zei Regarding Article, “Modifiable Risk Factors and Atrial Fibrillation”
Paul C. Zei

Circulation. 2018;137:1530-1531, originally published April 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031261

Download PDF
You have accessRestricted access
Letter by Borghi and Cicero Regarding Article, “Modifiable Risk Factors and Atrial Fibrillation”
Claudio Borghi and Arrigo F.G. Cicero

Circulation. 2018;137:1532-1533, originally published April 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031291

Download PDF
You have accessRestricted access
Response by Lau et al to Letters Regarding Article, “Modifiable Risk Factors and Atrial Fibrillation”
Dennis H. Lau, Stanley Nattel, Jonathan M. Kalman and Prashanthan Sanders

Circulation. 2018;137:1534-1535, originally published April 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032205

Download PDF
You have accessRestricted access
Letter by Jin-shan and Xue-bin Regarding Article, “Worsening Conduction Delay in Hypertrophic Cardiomyopathy: What Drug Is Responsible?”
He Jin-shan and Li Xue-bin

Circulation. 2018;137:1540, originally published April 2, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031756

Download PDF
You have accessRestricted access
Letter by Cerit Regarding Article, “Cerebral Perfusion and the Risk of Dementia: A Population-Based Study”
Levent Cerit

Circulation. 2018;137:1413, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.031349

Download PDF
You have accessRestricted access
Response by Wolters and Ikram to Letter Regarding Article, “Cerebral Perfusion and the Risk of Dementia: A Population-Based Study”
Frank J. Wolters and M. Arfan Ikram

Circulation. 2018;137:1416-1417, originally published March 26, 2018
https://doi.org/10.1161/CIRCULATIONAHA.117.032341

Download PDF

Header Publisher Menu

Circulation

Atrial Fibrillation

Pages

Current Issue

Search This Journal

Related Collections

Customer Service

About Us

Our Sites

Take Action

Online Communities